Cargando…
Alix: A Candidate Serum Biomarker of Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common fatal neurodegenerative disease of the elderly worldwide. The identification of AD biomarkers will allow for earlier diagnosis and thus earlier intervention. The aim of this study was to find such biomarkers. It was observed that the expression of Alix was...
Autores principales: | Sun, Yingni, Hua, Jin, Chen, Gen, Li, Jianjie, Yang, Jiateng, Gao, Hongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239346/ https://www.ncbi.nlm.nih.gov/pubmed/34211388 http://dx.doi.org/10.3389/fnagi.2021.669612 |
Ejemplares similares
-
Cofilin 2 in Serum as a Novel Biomarker for Alzheimer’s Disease in Han Chinese
por: Sun, Yingni, et al.
Publicado: (2019) -
Plasma-Derived Exosomal ALIX as a Novel Biomarker for Diagnosis and Classification of Pancreatic Cancer
por: Yang, Jie, et al.
Publicado: (2021) -
A Strategy for Discovery and Verification of Candidate Biomarkers in Cerebrospinal Fluid of Preclinical Alzheimer’s Disease
por: Zhong, Xiaofang, et al.
Publicado: (2019) -
Increased central auditory gain in 5xFAD Alzheimer’s disease mice as an early biomarker candidate for Alzheimer’s disease diagnosis
por: Na, Daxiang, et al.
Publicado: (2023) -
Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
por: Huang, Yuehua, et al.
Publicado: (2022)